Opens print. Choose "Save as PDF" and turn on background graphics. MedPrep
Serum K+ 5.5 mmol/L or higher
v

Exclude pseudohyperkalaemia

  • Suspect with haemolysis, delayed sample processing, very high platelets or white cells, or a difficult draw
  • Repeat as paired lithium heparin and clotted samples from a large vein with gentle traction
  • Do not delay treatment if the ECG is abnormal

1. Initial assessment (all patients)

  • ABCDE approach. Give empirical treatment for arrhythmia if hyperkalaemia is strongly suspected
  • Point-of-care blood gas K+ while awaiting the lab result
  • Urgent 12-lead ECG if K+ is 6.0 mmol/L or higher
  • Continuous cardiac monitoring if K+ is 6.5 or higher, if ECG changes, or if K+ 6.0 to 6.4 and unwell or rising fast
  • Identify and treat the cause: AKI, drugs, acidosis, tissue breakdown, adrenal insufficiency
v
ECG changes of hyperkalaemia?
v
YES

Step 1. Protect the heart: IV calcium

  • Calcium gluconate 10%, 30 mL IV over 10 min via a large vein (contains about 6.8 mmol calcium), OR
  • Calcium chloride 10%, 10 mL over 5 min (preferred in cardiac arrest or peri-arrest, give via central access)
  • Onset 1 to 3 min, lasts 30 to 60 min. Repeat ECG and give a further dose after 5 min if changes persist
  • Calcium protects the myocardium but does NOT lower K+. Still proceed to shift and remove
NO

Assess by potassium level (below)

  • No ECG changes does not mean safe. Treat by level, rate of rise and clinical state
  • Recheck K+ and keep on monitoring if rising
vCLASSIFY SEVERITY (UKKA)

Mild: 5.5 to 5.9

  • Emergency treatment not usually needed
  • Find and treat the cause
  • Review and stop K+ raising drugs; withhold RAASi if acutely unwell
  • Recheck K+ and go to Step 5

Moderate: 6.0 to 6.4

  • Treatment guided by clinical state, ECG and rate of rise
  • Consider insulin-glucose and salbutamol (Step 2)
  • Consider a K+ binder (Step 3)
  • Monitor and seek senior or renal review

Severe: 6.5 or higher

  • Emergency treatment indicated now
  • Continuous cardiac monitoring
  • Give IV calcium if any ECG changes
  • Urgent renal or critical care opinion. Dialysis patients: urgent dialysis
v
2

Shift K+ into cells (severe: give; moderate: consider)

  • Insulin-glucose: 10 units soluble insulin in 25 g glucose IV over 15 to 30 min (25 g = 50 mL of 50%, or 125 mL of 20%, or 250 mL of 10% glucose)
  • If pre-treatment glucose is below 7.0 mmol/L, follow with 10% glucose at 50 mL/h for 5 h
  • Consider sodium bicarbonate only on specialist advice if significant metabolic acidosis
Adjunct: salbutamol 10 to 20 mg nebulised. Give with insulin-glucose in severe cases; may be used in moderate. Never as sole treatment in severe hyperkalaemia (beware tachycardia).
v
3

Remove K+ from the body

  • Sodium zirconium cyclosilicate 10 g three times daily for up to 72 h (severe: give; moderate: consider)
  • Or patiromer 8.4 g once daily if K+ is 6.0 or higher (not routinely available in Scotland)
  • Loop diuretic (for example furosemide) if fluid overloaded and passing urine
  • Calcium resonium is no longer routinely used
  • Haemodialysis if refractory, anuric, or life-threatening. Discuss early
v
4

Monitor

  • Serum K+ at least at 1, 2, 4, 6 and 24 h after treatment
  • Blood glucose at 0, 30, 60, 90, 120, 180, 240, 300 and 360 min after insulin-glucose
  • Watch for rebound hyperkalaemia and for hypoglycaemia
v
K+ still 6.5 or higher despite treatment?
v
YES

Life-threatening hyperkalaemia

  • Seek expert help now: urgent nephrology or critical care review
  • Consider dialysis (timing and modality decided by a nephrologist or intensivist)
  • Critical care first if ABCDE or conscious-level problems
5

Prevent recurrence (NO)

  • Review K+ raising medicines; withhold RAASi during acute illness and weigh recurrence risk before restarting
  • Dietary K+ advice once constipation, acidosis and poor diabetes control are addressed
  • Arrange community K+ monitoring on discharge
v
Hyperkalaemic ECG changes (reference)
K+ (mmol/L)Typical change
5.5 to 6.0Peaked, tented T waves (compare with an old ECG)
6.0 to 6.5PR prolongation, flattened or absent P waves, broadening QRS
Above 6.5Sine wave pattern, bradyarrhythmia, VT or VF, asystole

MedPrep - www.medprep.uk - Educational revision aid only. Not clinical guidance. Doses are adult examples; check the BNF, the current UK Kidney Association guideline and local trust policy, and seek senior advice. Nov 2026.